- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Aflibercept
Total 480 results
-
Regeneron PharmaceuticalsSanofiCompletedSolid TumorsUnited States, Canada
-
Qena Faculty of medicine, South Valley UniversityRecruitingNon-Ischemic Central Retinal Vein Occlusion With Macular EdemaEgypt
-
CR-CSSS Champlain-Charles-Le MoyneSanofi; Regeneron Pharmaceuticals; Quebec Clinical Research Organization in CancerTerminatedMetastatic Colorectal CancerCanada
-
Samsung Bioepis Co., Ltd.CompletedNeovascular Age-related Macular DegenerationCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Poland, United States, Croatia, Japan, Russian Federation
-
Alvotech Swiss AGActive, not recruitingNeovascular (Wet) AMDSlovakia, Czechia, Georgia, Japan, Latvia
-
Bioeq GmbHCompletedNeovascular Age-related Macular DegenerationBulgaria, Italy, Poland, Russian Federation, Hungary, Ukraine, Japan, Israel, Czechia
-
Regeneron PharmaceuticalsBayerCompletedNeovascular (Wet) Age-Related Macular DegenerationUnited States, Puerto Rico
-
Regeneron PharmaceuticalsBayerActive, not recruitingType 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes MellitusUnited States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary
-
Instituto de Olhos de GoianiaCompleted
-
SanofiRegeneron PharmaceuticalsCompletedNeoplasms | Cancer of the OvaryUnited States, France, Canada, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland
-
SanofiRegeneron PharmaceuticalsCompletedOvarian NeoplasmsUnited States, Italy, Sweden
-
SanofiRegeneron PharmaceuticalsCompletedNeoplasms, Lung | Pulmonary DiseasesUnited States, France, Canada
-
CinnagenCompletedAge-Related Macular Degeneration | Neovascular Age-related Macular DegenerationIran, Islamic Republic of
-
Instituto de Olhos de GoianiaUnknownChoroidal Retinal NeovascularizationBrazil
-
SanofiRegeneron PharmaceuticalsCompletedOvarian Neoplasms | AscitesUnited States, Canada, Spain, India, Belgium, Austria, Hungary, Israel, United Kingdom
-
Kim's Eye HospitalBayerRecruitingRetinal Angiomatous ProliferationKorea, Republic of
-
Emory UniversityWithdrawn
-
Kapil KapoorCompletedWet Macular Degeneration | Wet Age-related Macular DegenerationUnited States
-
Washington University School of MedicineRegeneron PharmaceuticalsCompletedMacular Edema | Radiation RetinopathyUnited States
-
Indonesia UniversityBayerCompletedDiabetic Retinopathy | Diabetic Macular Edema | Clinically Significant Macular EdemaIndonesia
-
GCS IHFB Cognacq-JayFondation ARCADActive, not recruiting
-
Regeneron PharmaceuticalsCompletedNonproliferative Diabetic RetinopathyUnited States, Germany, Hungary, Japan, Puerto Rico, United Kingdom
-
Regeneron PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationUnited States
-
Regeneron PharmaceuticalsBayerCompleted
-
Tennessee RetinaRegeneron PharmaceuticalsUnknownNeovascular Age-related Macular DegenerationUnited States
-
Shahid Beheshti University of Medical SciencesUnknownDiabetic Macular EdemaIran, Islamic Republic of
-
Singapore National Eye CentreBayerCompletedAge Related Macular Degeneration | Polypoidal Choroidal VasculopathySingapore
-
National Cancer Institute (NCI)CompletedMetastatic Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
John Kitchens, MDUnknown
-
OxurionCompletedDiabetes Mellitus | Diabetic Retinopathy | Diabetic Macular EdemaUnited States, France, United Kingdom, Spain, Germany, Italy, Slovakia, Czechia
-
National Cancer Institute (NCI)CompletedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerCanada
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Uterine Carcinosarcoma | Stage IV Ovarian Epithelial Cancer | Ovarian Sarcoma | Recurrent Uterine Sarcoma | Stage III Uterine Sarcoma | Stage IV Uterine Sarcoma | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian Carcinosarcoma | Female Reproductive... and other conditionsUnited States, Canada
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States
-
Poitiers University HospitalActive, not recruiting
-
Hospices Civils de LyonCompletedStudy Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients (INTUITION)Idiopathic Choroidal NeovascularizationFrance
-
GERCOR - Multidisciplinary Oncology Cooperative...SanofiCompletedUnresectable Metastatic Colorectal CancerFrance
-
Fondation Ophtalmologique Adolphe de RothschildCompletedPolypoidal Choroidal VasculopathyFrance
-
Regeneron PharmaceuticalsNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); National Institutes of Health (NIH); Regeneron...CompletedDiabetic Macular EdemaUnited States, Canada
-
Kamal Kishore, MDUnknownMacular Edema | Retinal Artery MacroaneurysmUnited States
-
Manhattan Eye, Ear & Throat HospitalNorthwell HealthWithdrawnPattern Dystrophy of MaculaUnited States
-
Larkin Community HospitalCompletedAdverse Effect of Radiation Therapy
-
Dana-Farber Cancer InstituteCompleted
-
Rishi SinghRegeneron PharmaceuticalsCompletedDiabetic Retinopathy | Macular EdemaUnited States
-
Southeast Clinical Research Associates, LLCRegeneron PharmaceuticalsWithdrawnDiabetic Macular EdemaUnited States
-
Regeneron PharmaceuticalsNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
BayerRegeneron PharmaceuticalsActive, not recruitingNeovascular Age-Related Macular DegenerationUnited States, Spain, Korea, Republic of, Czechia, Japan, Singapore, China, Serbia, Lithuania, Taiwan, Australia, Estonia, Austria, Israel, France, Italy, Switzerland, Slovakia, Ukraine, Bulgaria, Portugal, Latvia, Canada, Hungary, Arge... and more
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Endometrial CarcinomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingNeovascular Age-related Macular DegenerationChina
-
Stanford UniversityRegeneron PharmaceuticalsWithdrawnDiabetic Macular EdemaUnited States